Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,474 INR | -0.72% | +6.20% | -4.03% |
May. 14 | Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 | MT |
May. 13 | Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.03% | 2.48B | |
-16.80% | 8.79B | |
+67.50% | 4.19B | |
-42.54% | 2.29B | |
-6.49% | 1.97B | |
-20.45% | 1.56B | |
-41.24% | 1.22B | |
+10.26% | 1.13B | |
+18.74% | 933M | |
-10.60% | 910M |
- Stock Market
- Equities
- LALPATHLAB Stock
- News Dr. Lal PathLabs Limited
- Nomura Upgrades Dr. Lal Pathlabs to Neutral From Reduce, Adjusts Price Target to INR2,465 From INR,2002